Section Arrow
TLRY.NASDAQ
- Tilray Brands
Quotes are at least 15-min delayed:2025/11/07 08:41 EST
Pre Market
Last
 1.21
0 (0.00%)
Bid
1.21
Ask
1.22
High 1.25 
Low 1.1902 
Volume 590650 
Regular Hours
Last
 1.21
-0.07 (-5.47%)
Day High 
1.28 
Prev. Close
1.28 
1-M High
2.32 
Volume 
36.35M 
Bid
1.21
Ask
1.22
Day Low
1.2 
Open
1.265 
1-M Low
1.21 
Market Cap 
1.44B 
Currency USD 
P/E -- 
%Yield -- 
10-SMA 1.36 
20-SMA 1.5 
50-SMA 1.4 
52-W High 2.32 
52-W Low 0.3507 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-2.42/-0.05
Enterprise Value
1.74B
Balance Sheet
Book Value Per Share
1.37
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
821.31M
Operating Revenue Per Share
0.58
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
HIMSHims & Hers Health41.52-2.21-5.05%83.3PE
Pre Market 40.64 -0.88 -2.12%
TLRYTilray Brands1.21-0.07-5.47%-- 
Pre Market 1.21 0 0.00%
TEVATeva Pharmaceutical Industries Limited24.46-0.14-0.57%-- 
Pre Market 24.15 -0.31 -1.27%
CGCCanopy Growth Corp1.09-0.05-4.39%-- 
Pre Market 1.29 +0.2 +18.35%
VTRSViatris10.11-0.64-5.95%227.2PE
Pre Market 10.1 -0.01 -0.10%
Quotes are at least 15-min delayed:2025/11/07 08:41 EST
Industry overview quotes are at least 15 minutes delayed
Business Description
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure comes mostly from alcohol.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.